In this episode of the Huberman Lab, Dr. Michael Kilgard discusses the brain's ability to change throughout life, challenging the old belief that significant brain changes only occur during childhood. He explains how neuromodulators—chemicals in the brain including acetylcholine, norepinephrine, serotonin, and dopamine—affect learning and neuroplasticity, and describes the optimal conditions for brain changes to occur.
Drawing from his research, Kilgard shares insights about treating neurological conditions through targeted vagus nerve stimulation. He outlines how this approach has helped patients with tinnitus, stroke effects, and spinal cord injuries by retraining neural circuits. The discussion explores how combining devices, drugs, and training could create more effective treatments for various brain conditions, moving beyond symptom management toward complete cures.
Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
In a discussion between Andrew Huberman and Dr. Michael Kilgard, they explore how our understanding of neuroplasticity has evolved. While scientists once believed that significant brain changes were limited to childhood, Kilgard's research in the late 1990s demonstrated that adult brains can undergo substantial rewiring under the right conditions. Through his personal experience with amblyopia correction in adulthood, Kilgard illustrates how the brain maintains its capacity for change well beyond early childhood.
Huberman and Kilgard explain that neuromodulators—including acetylcholine, [restricted term], serotonin, and [restricted term]—play a crucial role in learning and neuroplasticity. Kilgard describes how the timing of neuromodulator release is critical, following what he calls the "four-factor learning rule." This biological basis for learning shows how the brain strengthens or weakens connections based on experience. They note that while these neuromodulators are necessary for neuroplasticity, there's an optimal range—too much can actually impair memory formation.
Kilgard's research has led to breakthrough treatments using targeted vagus nerve stimulation to promote beneficial neural plasticity. His team developed an implanted device that can help patients overcome conditions such as tinnitus, stroke effects, and spinal cord injuries by retraining neural circuits. The approach has shown particular success in restoring hand function in stroke patients. Beyond these applications, Kilgard discusses the potential for neuroplasticity therapies to address severe PTSD and other mental health conditions, aiming for complete cures rather than just symptom management.
Given the brain's trillion-plus synaptic connections and constant computations, Kilgard emphasizes that there can't be a "silver bullet" solution for brain disorders. Instead, he advocates for comprehensive treatments that combine various approaches to leverage neuroplasticity effectively.
Kilgard's research demonstrates that precise timing in brain stimulation is crucial for facilitating neuroplasticity. His vagus nerve stimulation device, about the size of a pinky nail, has shown impressive results in patients even years after implantation. While discussing various treatment approaches, including SSRIs and psychedelics, Huberman and Kilgard stress the importance of integrating devices, drugs, and training to create comprehensive treatment packages for brain conditions.
1-Page Summary
Huberman and Dr. Michael Kilgard delved into the intricate landscape of neuroplasticity, revealing that age is not as much of a barrier to brain growth and reorganization as once thought.
For a century, the prevailing belief in neuroscience was that young brains possessed a high degree of plasticity, while adult brains were significantly less capable of learning and rewiring. Huberman emphasizes that his colleague’s research pertains to plasticity in the adult brain, countering this traditional view.
He notes that science supports the idea that the brain's passive reorganization happens robustly until about age 25 but also underscores that significant changes can occur in adulthood. Dr. Michael Kilgard has been instrumental in this area, demonstrating through research in the late 1990s that adult brains can indeed undergo massive changes under the right conditions.
Kilgard reveals that every experience we have — from bedtime stories to walks in the park — influences the brain's wiring, suggesting that adult brains retain the capacity for plasticity beyond early childhood. This concept overturns the long-held belief that the brain is rather static and unchangeable after a certain age.
Emphasizing the duration of this flexible window, ...
The History and Current Understanding of Neuroplasticity
Neuroplasticity is the brain’s ability to reorganize itself by forming new neural connections throughout life, which is instrumental in the process of learning. Recent insights into neuromodulators offer a deeper understanding of their vital role in this process.
Michael Kilgard and Andrew Huberman discuss the foundational role played by neuromodulators such as acetylcholine, [restricted term], serotonin, and [restricted term] in neuroplasticity and learning. Huberman describes how neuromodulators amplify the activity of neural circuits related to plasticity, especially during active engagement and self-directed learning activities.
Kilgard details the importance of the timing of neuromodulator release in the adult brain, which can lead to significant rewiring of circuits and enable learning. He highlights an experiment with monkeys, where focusing on a stimulus results in increased neuron response due to the stimulus's relevance and reward, emphasizing the role of acetylcholine in memory and attention. Kilgard explains that the timing of neuromodulator release is crucial; it can dictate whether synaptic connections will be stronger or weaker, with proper timing leading to long-term potentiation (strengthening) or long-term depression (weakening).
Kilgard sheds light on a biological basis for learning, known as the "four-factor learning rule," where certain proteins and receptors bind neurotransmitters such as glutamate, serotonin, and [restricted term]. This rule illustrates the brain’s ability to adapt connections based on experience.
Huberman and Kilgard stress that the brain's adaptation and learning heavily depend on the timing of neuromodulator release. They discuss how consistent and repeated association conditions synapses to be strengthened or weakened, indicating that experiences like making bagels or meaningful interactions can have lasting effects and create meaning.
Furthermore, Kilgard describes the inverted U effect with neuromodulators s ...
The Role of Neuromodulators in Neuroplasticity and Learning
Advancements in the field of neuroscience offer new pathways to treat neurological and psychiatric conditions by harnessing the brain's ability to reorganize itself, known as neuroplasticity.
Michael Kilgard's research explores how targeted vagus nerve stimulation can promote beneficial neural plasticity and considerable advancements in the treatment of various conditions.
Kilgard discovered that by stimulating specific brain circuits using devices like microelectrodes, one can enhance neuroplasticity. This technique, initially built upon the successes of deep brain stimulation, retargeted its focus to the more accessible method of vagus nerve stimulation due to its impact on the brain globally. Funded by DARPA for the Targeted Neuroplasticity Training (TNT) program, Kilgard's team developed an implanted device to stimulate the vagus nerve, which releases neuromodulators at precise timings. This breakthrough made it possible for people to overcome conditions such as tinnitus, stroke, and spinal cord injuries by retraining neural circuits. Human studies have shown significant gains in stroke patients, particularly in restoring hand function, which were unachievable without this technology.
Kilgard has described a detailed approach for treating tinnitus that includes sound therapy to retrain neural circuits by narrowing the receptive fields that contribute to the condition. His team's successful methods targeted spinal cord injuries and stroke, with stroke being the focus due to its clear causes and measurable outcomes. The goal is to activate neurons beyond traditional therapies, enhancing neuroplasticity and allowing patients to lose their diagnosis. It is important to note that Kilgard is an inventor and shareholder in Microtransponder, the company offering this technology.
Neuroplasticity therapies offer hope beyond the treatment of tinnitus, strokes, and spinal cord injuries. Kilgard discusses the potential for these therapies to address severe and persistent PTSD by helping those 'stuck' due to traumatic events to retrain the brain. He highlights the need for new avenues in neuroscience to ...
Applying Neuroplasticity to Treat Neurological and Psychiatric Conditions
Michael Kilgard highlights the intricate structure and operation of the human brain and the challenges it presents for treating brain disorders, advocating for comprehensive treatments that leverage neuroplasticity.
Kilgard speaks on the sophistication of the human brain, emphasizing that it runs on a much larger network than artificial intelligence systems, with trillions of computations happening simultaneously. He marvels at the trillions of connections being made every second, pointing out that the brain dynamically decides whether to strengthen, weaken, or maintain synapses.
The brain's complexity and the adaptability of its synapses suggest that simple, one-size-fits-all solutions for brain disorders are unlikely, emphasizes Kilgard. He compares the brain's complexity to the vastness and variability of ecosystems or economic systems, where a multitude of interconnected issues exist rather than a single problem to solve.
Kilgard suggests that because of the brain's intricacy and the diversity in individual experiences, understanding and addressing it necessitates a complex approach that accounts for the various inputs that influence its function and adaptation.
Brain Complexity: A Multifaceted Approach Needed
Advancements in neuroscience are revealing more about how to optimize neuroplasticity—the brain's ability to change and adapt. Researchers are finding that combining different treatments can make a significant impact on brain function.
Michael Kilgard’s research shows that precise timing in brain stimulation is crucial to facilitate neuroplasticity, similar to Pavlov's classical conditioning experiments. His approach involves using timed devices, such as vagus nerve stimulators, which enhance neuroplasticity through the targeted delivery of neuromodulator bursts enabling therapeutic rewiring of neural circuits.
Kilgard hypothesizes that by externally activating neurons with an electrode—potentially through vagus nerve stimulation—a burst of acetylcholine is released, mirroring the natural occurrence when an animal focuses or pays attention, thus enhancing neuroplasticity and function. Kilgard explains that his vagus nerve stimulation device, which provides brief bursts, activates three crucial neurotransmitters, enhancing neuroplasticity and the function of neural circuits.
Kilgard's research includes the use of a vagus nerve stimulator, a device that he works with that achieves impressive results by increasing specificity and avoiding the need to take a drug. Kilgard points out that even years post-implantation, patients continue to make gains, suggesting that significant neural plasticity can occur even in stages previously thought to be beyond improvement. Huberman compares the stimulator device Kilgard uses to the size of a Carmex lip balm container, with the chip itself being the size of a pinky nail, illustrating the device's convenience and potential for everyday use.
A multifaceted approach is essential to optimize neuroplasticity. The conversation involves SSRIs as tools to induce neuroplasticity, which can be an essential part of treatment for conditions like OCD when combined with activities that promote neuroplasticity. The potential role of psychedelics and empathogens in promoting plasticity is also discussed, suggesting that the experience they facilitate may lead to change.
However, a large-scale randomized trial with stroke patients using [restricted term] ([restricted term]) found no significant improvement and even unintended side effects like increased hip fractures, highlighting the complexity of neuroplasticity and the need for multifaceted approaches to treatment.
Kilgard talks about combining therapies for complex problems such as obesity and neurodevelopmental disorders. He mentions the FDA challenge in proposing multiple forms of ther ...
Combining Devices, Drugs, and Training to Optimize Neuroplasticity
Download the Shortform Chrome extension for your browser